{"id":24606,"date":"2022-11-07T01:35:00","date_gmt":"2022-11-06T17:35:00","guid":{"rendered":"https:\/\/flcube.com\/?p=24606"},"modified":"2025-02-01T01:39:25","modified_gmt":"2025-01-31T17:39:25","slug":"organon-signs-mou-with-chinas-national-health-commission-at-ciie","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=24606","title":{"rendered":"Organon Signs MOU with China’s National Health Commission at CIIE"},"content":{"rendered":"\n

Organon & Co. (NYSE: OGN<\/a>), a firm with a strong focus on women’s health that split from Merck, Sharp & Dohme (MSD, NYSE: MRK<\/a>) in mid-2021, announced at the 5th China International Import Expo (CIIE) the signing of a memorandum of understanding (MOU) with the National Health Commission (NHC). The long-term partnership aims to leverage the respective resource advantages of government, enterprise, academia, and medicine to empower primary general practitioners (GPs) in China.<\/p>\n\n\n\n

Partnership with National Health Commission<\/strong>
The collaboration with the NHC is designed to enhance the capabilities of primary care physicians in China by integrating resources from multiple sectors. This initiative underscores Organon’s commitment to improving healthcare outcomes and supporting the professional development of GPs in the country.<\/p>\n\n\n\n

Partnership with Baidu Health<\/strong>
On the same day, Organon also announced a partnership with Baidu Health, the one-stop health management platform of China-based Internet giant Baidu. The collaboration will utilize Organon\u2019s medical science expertise and Baidu Health\u2019s technological advantages to explore precision digital disease and health education services, focusing on common chronic diseases. This strategic move aims to improve patient outcomes through innovative digital health solutions.<\/p>\n\n\n\n

Future Prospects<\/strong>
These partnerships highlight Organon’s ongoing efforts to advance women’s health and digital health initiatives in China. By working with key stakeholders, Organon aims to enhance healthcare delivery and improve access to quality medical services for patients.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Organon & Co. (NYSE: OGN), a firm with a strong focus on women’s health that…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[1358,30,95,2675,122,176,60,903,972,174],"class_list":["post-24606","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-baidu-health","tag-biotech","tag-healthcare-big-data","tag-merck-sharp-dohme","tag-mobile-health-app","tag-msd","tag-nhc-nhfpc","tag-nyse-mrk","tag-nyse-ogn","tag-organon"],"yoast_head":"\nOrganon Signs MOU with China's National Health Commission at CIIE - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Organon & Co. (NYSE: OGN), a firm with a strong focus on women's health that split from Merck, Sharp & Dohme (MSD, NYSE: MRK) in mid-2021, announced at the 5th China International Import Expo (CIIE) the signing of a memorandum of understanding (MOU) with the National Health Commission (NHC). The long-term partnership aims to leverage the respective resource advantages of government, enterprise, academia, and medicine to empower primary general practitioners (GPs) in China.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=24606\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Organon Signs MOU with China's National Health Commission at CIIE\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=24606\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-06T17:35:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-31T17:39:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24606#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24606\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Organon Signs MOU with China’s National Health Commission at CIIE\",\"datePublished\":\"2022-11-06T17:35:00+00:00\",\"dateModified\":\"2025-01-31T17:39:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24606\"},\"wordCount\":245,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Baidu Health\",\"Biotech\",\"Healthcare Big Data\",\"Merck Sharp & Dohme\",\"Mobile health \\\/ APP\",\"MSD\",\"NHC (NHFPC)\",\"NYSE: MRK\",\"NYSE: OGN\",\"Organon\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=24606#respond\"]}],\"copyrightYear\":\"2022\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24606\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=24606\",\"name\":\"Organon Signs MOU with China's National Health Commission at CIIE - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2022-11-06T17:35:00+00:00\",\"dateModified\":\"2025-01-31T17:39:25+00:00\",\"description\":\"Organon & Co. (NYSE: OGN), a firm with a strong focus on women's health that split from Merck, Sharp & Dohme (MSD, NYSE: MRK) in mid-2021, announced at the 5th China International Import Expo (CIIE) the signing of a memorandum of understanding (MOU) with the National Health Commission (NHC). The long-term partnership aims to leverage the respective resource advantages of government, enterprise, academia, and medicine to empower primary general practitioners (GPs) in China.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24606#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=24606\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24606#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Organon Signs MOU with China’s National Health Commission at CIIE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Organon Signs MOU with China's National Health Commission at CIIE - Insight, China's Pharmaceutical Industry","description":"Organon & Co. (NYSE: OGN), a firm with a strong focus on women's health that split from Merck, Sharp & Dohme (MSD, NYSE: MRK) in mid-2021, announced at the 5th China International Import Expo (CIIE) the signing of a memorandum of understanding (MOU) with the National Health Commission (NHC). The long-term partnership aims to leverage the respective resource advantages of government, enterprise, academia, and medicine to empower primary general practitioners (GPs) in China.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=24606","og_locale":"en_US","og_type":"article","og_title":"Organon Signs MOU with China's National Health Commission at CIIE","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=24606","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2022-11-06T17:35:00+00:00","article_modified_time":"2025-01-31T17:39:25+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=24606#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=24606"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Organon Signs MOU with China’s National Health Commission at CIIE","datePublished":"2022-11-06T17:35:00+00:00","dateModified":"2025-01-31T17:39:25+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=24606"},"wordCount":245,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Baidu Health","Biotech","Healthcare Big Data","Merck Sharp & Dohme","Mobile health \/ APP","MSD","NHC (NHFPC)","NYSE: MRK","NYSE: OGN","Organon"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=24606#respond"]}],"copyrightYear":"2022","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=24606","url":"https:\/\/flcube.com\/?p=24606","name":"Organon Signs MOU with China's National Health Commission at CIIE - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2022-11-06T17:35:00+00:00","dateModified":"2025-01-31T17:39:25+00:00","description":"Organon & Co. (NYSE: OGN), a firm with a strong focus on women's health that split from Merck, Sharp & Dohme (MSD, NYSE: MRK) in mid-2021, announced at the 5th China International Import Expo (CIIE) the signing of a memorandum of understanding (MOU) with the National Health Commission (NHC). The long-term partnership aims to leverage the respective resource advantages of government, enterprise, academia, and medicine to empower primary general practitioners (GPs) in China.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=24606#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=24606"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=24606#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Organon Signs MOU with China’s National Health Commission at CIIE"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/24606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=24606"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/24606\/revisions"}],"predecessor-version":[{"id":24607,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/24606\/revisions\/24607"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=24606"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=24606"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=24606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}